Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bydureon for Weight Loss Maintenance in Adolescents
NCT02496611Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Dec 2015
- Primary completion
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of exenatide in obesity, sponsored by University of Minnesota. Started Dec 2015; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02496611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496611.